Figure 1.
CTCF occupancy and its distribution within the genome. (A) Experimental outline illustrating the analyses of patient samples. (B) Venn diagram displaying unique and common CTCF peaks in AMLall and NBM cells. (C) Distribution of CTCF-binding sites over genomic features. (D) Percentage of enhancers that contain a CTCF-binding site (Z-test, *P < .01). (E) Heatmap of unsupervised hierarchical clustering for the 1000 most variably bound CTCF peaks based on interquartile range measure. DMSO, dimethyl sulfoxide; UTR, untranslated region.

CTCF occupancy and its distribution within the genome. (A) Experimental outline illustrating the analyses of patient samples. (B) Venn diagram displaying unique and common CTCF peaks in AMLall and NBM cells. (C) Distribution of CTCF-binding sites over genomic features. (D) Percentage of enhancers that contain a CTCF-binding site (Z-test, *P < .01). (E) Heatmap of unsupervised hierarchical clustering for the 1000 most variably bound CTCF peaks based on interquartile range measure. DMSO, dimethyl sulfoxide; UTR, untranslated region.

Close Modal

or Create an Account

Close Modal
Close Modal